NCT01830088

Brief Summary

Major depressive disorder (MDD) affects about 5% of adolescents and is on the rise both internationally and in Norway. Further, it is also associated with increased risk for suicide. Not surprisingly, depression is the largest reason for referral to specialty mental health services for adolescents (13-17 years) in Norway. Although anti-depressants and Cognitive behavioral therapy are strong treatments and have received extensive research, the best treatments show a recovery rate of only 37 %. There is a need to develop and test alternative treatments that can stand alone or augment anti-depressant medication. Family factors play an important role in the etiology, maintenance and relapse of depression. A promising family-based treatment (Attachment based family therapy- ABFT) was imported to Norway and its feasibility tested in a pilot randomized clinical trial with 20 families. The results showed promising treatment outcomes. Although the developers of the model have refined, adapted the model to suicidal ideation and built strong technology to support dissemination, a definitive study of ABFT for adolescents with major depression has not yet been conducted. Therefore the primary aim of this study is to test if ABFT is more effective that enhanced usual care (EUC) to treat clinic-referred adolescents with major depression. The investigators will test the hypothesis that 12 weeks of ABFT therapy will produce a greater proportion of adolescents report remission from depression and symptom change than 12 weeks of enhanced clinical care (EUC). Secondary research aims are i) to test a hypothesis that parent-adolescent conflict will be more sensitive to change for adolescents receiving ABFT that adolescents receiving EUC ii) to explore patterns of change in suicidal ideation in the recruited sample in the acute-phase treatment. Central challenges to the study are i) blinding therapists/patients, which is difficult in psychotherapy trials ii) lack of a standardized control condition, and iii) selecting and training regular staff therapists to high adherence levels. However, with tighter control over these factors than is normal for a typical effectiveness trial, the investigators expect results to show what to expect under the "best of conditions" in community clinics. Benchmark derived from the study will inform how to effectively train therapists and subsequently implement the model into mainstream services.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 8, 2013

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 12, 2013

Completed
6 months until next milestone

Study Start

First participant enrolled

October 1, 2013

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2016

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
Last Updated

May 11, 2018

Status Verified

May 1, 2018

Enrollment Period

2.3 years

First QC Date

April 8, 2013

Last Update Submit

May 4, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in Hamilton Depression Rating scale

    The Hamilton Depression Rating Scale (17 item) version is a 17-item, semi-structured interview and is currently a widely used clinical measure depression. Grid HamD (Williams 2008) version is used.

    12, 24 and 48 weeks

Secondary Outcomes (2)

  • Beck depression Inventory (BDI-II)

    Bi-weekly for 12 weeks, and at week 24 and week 48

  • Kiddie-SADS (Diagnostic interview)

    Baseline and 26 weeks

Other Outcomes (1)

  • Change from baseline in Conflict Behavior Questionnaire

    Biweekly for 12 weeks and week 24

Study Arms (2)

Attachment Based Family Therapy

EXPERIMENTAL

Attachment-Based Family Therapy (ABFT) is primarily a process oriented, emotion focused treatment guided by a semi-structured treatment protocol. ABFT aims to improve the family's capacity for problem solving, affect regulation, and organization. This strengthens family cohesion which can buffer against depression, suicidal thinking, and risk behaviors

Behavioral: Attachment Based Family Therapy

Enhanced Usual Care

ACTIVE COMPARATOR

No attempt is made to control any aspect of the enhanced usual care except for pre-scheduled assessment plan

Behavioral: Enhanced Usual Care

Interventions

Attachment-Based Family Therapy (ABFT) is is primarily a process oriented, emotion focused treatment guided by a semi-structured treatment protocol. ABFT aims to improve the family's capacity for problem solving, affect regulation, and organization. This strengthens family cohesion which can buffer against depression, suicidal thinking, and risk behaviors

Also known as: ABFT
Attachment Based Family Therapy

No attempt is made to control any aspect of the enhanced usual care except for pre-scheduled assessment plan

Also known as: EUC
Enhanced Usual Care

Eligibility Criteria

Age13 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Adolescents between ages 13-17 years
  • Adolescents endorsing depression symptoms (HAM-D ≥ 16) on the HAM-D
  • Adolescents meet diagnostic criteria for major depressive disorder (MDD) as assessed by Kiddie SADS
  • At least one primary parent or caregiver must participate in the assessment and treatment

You may not qualify if:

  • psychotic disorder
  • anorexia nervosa
  • severe substance dependence disorders
  • mental retardation (IQ less than 70 as assessed by the clinician)
  • asperger syndrome/autism as assessed by the K-SADS
  • Adolescents taking antidepressant medication for depression for less than 6 weeks prior to the screening

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Akershus University Hospital

Lorenskog, Akershus, 1478, Norway

Location

Related Publications (2)

  • Israel P, Diamond GS. Feasibility of Attachment Based Family Therapy for depressed clinic-referred Norwegian adolescents. Clin Child Psychol Psychiatry. 2013 Jul;18(3):334-50. doi: 10.1177/1359104512455811. Epub 2012 Aug 28.

    PMID: 22930777BACKGROUND
  • Waraan L, Rognli EW, Czajkowski NO, Aalberg M, Mehlum L. Effectiveness of attachment-based family therapy compared to treatment as usual for depressed adolescents in community mental health clinics. Child Adolesc Psychiatry Ment Health. 2021 Feb 12;15(1):8. doi: 10.1186/s13034-021-00361-x.

MeSH Terms

Conditions

Depressive DisorderMood DisordersDepressive Disorder, Major

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Marianne A Villabø, PhD

    University Hospital, Akershus

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcome assessors (HAM-D) are masked and do not know the treatment arm of the participant
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The two treatment arms are i) Attachment Based Family Therapy and ii) Treatment as usual
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher

Study Record Dates

First Submitted

April 8, 2013

First Posted

April 12, 2013

Study Start

October 1, 2013

Primary Completion

January 1, 2016

Study Completion

June 1, 2016

Last Updated

May 11, 2018

Record last verified: 2018-05

Locations